tiprankstipranks
Trending News
More News >
Aim Immunotech Inc. (AIM)
:AIM
US Market

AIM ImmunoTech (AIM) Income Statement

Compare
883 Followers

AIM ImmunoTech Income Statement

Last quarter (Q4 2024), AIM ImmunoTech's total revenue was $45.00K, a decrease of -30.77% from the same quarter last year. In Q4, AIM ImmunoTech's net income was $-5.97M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 170.00K$ 202.00K$ 141.00K$ 135.00K$ 163.00K
Gross Profit
$ 139.00K$ 160.00K$ -19.78M$ -715.00K$ -643.00K
Operating Expenses
$ 19.91M$ 32.08M$ 20.06M$ 16.34M$ 14.37M
Depreciation and Amortization
$ 246.00K$ 238.00K$ -424.00K$ 805.00K$ 706.00K
EBITDA
$ -16.49M$ -31.68M$ -19.87M$ -18.25M$ -13.02M
Operating Income
$ -19.77M$ -31.92M$ -19.92M$ -18.84M$ -15.15M
Other Income/Expenses
$ 2.45M$ 2.95M$ 478.00K$ -289.00K$ 752.00K
Pretax Income
$ -17.32M$ -28.96M$ -19.45M$ -19.13M$ -14.40M
Net Income
$ -17.32M$ -28.96M$ -21.09M$ -21.51M$ -16.26M
Per Share Metrics
Basic EPS
$ -0.31$ -0.60$ -0.44$ -0.45$ -0.51
Diluted EPS
$ -0.31$ -0.60$ -0.44$ -0.45$ -0.51
Weighted Average Shares Outstanding
56.02M 48.59M 48.05M 47.34M 31.84M
Weighted Average Shares Outstanding (Diluted)
56.02M 48.59M 48.05M 47.34M 31.84M
Currency in USD

AIM ImmunoTech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis